Cover Image
市場調查報告書

Opsona Therapeutics Ltd. - 產品平台分析

Opsona Therapeutics Ltd. - Product Pipeline Review - 2015

出版商 Global Markets Direct 商品編碼 309674
出版日期 內容資訊 英文 26 Pages
訂單完成後即時交付
價格
Back to Top
Opsona Therapeutics Ltd. - 產品平台分析 Opsona Therapeutics Ltd. - Product Pipeline Review - 2015
出版日期: 2015年06月24日 內容資訊: 英文 26 Pages
簡介

Opsona Therapeutics Ltd.正在進行自體免疫性,發炎性,癌症等疾病的治療研究,並提供治療藥。

本報告提供Opsona Therapeutics Ltd.的治療藥開發平台現狀及各開發階段比較分析,彙整藥物標的,作用機制,給藥途徑,各分子類型的治療藥評估,最新的企業新聞和發表,後期階段及中止的計劃等相關資訊。

Opsona Therapeutics Ltd.的基本資料

Opsona Therapeutics Ltd.概要

  • 主要資訊
  • 企業資料

Opsona Therapeutics Ltd.:R&D概要

  • 主要的治療範圍

Opsona Therapeutics Ltd.:開發平台的檢討

  • 各開發階段的開發中產品
  • 單劑產品

Opsona Therapeutics Ltd.:開發中產品概況

  • 臨床實驗階段的開發中產品
    • 第二階段的產品/聯合治療模式
  • 初期階段產品開發中產品
    • 前臨床階段的產品/聯合治療模式
    • 藥物研發中的產品/聯合治療模式

Opsona Therapeutics Ltd.:藥物簡介

  • OPN-305
  • OPN-401
  • Small Molecule Inflammasome Modulator Programme

Opsona Therapeutics Ltd.:開發平台分析

  • 標的別
  • 各給藥途徑
  • 各分子類型
  • 各作用機制

Opsona Therapeutics Ltd.:最近的開發平台趨勢

Opsona Therapeutics Ltd.:暫停中的計劃

Opsona Therapeutics Ltd.:總公司和子公司的所在地

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GMDHC07155CDB

Summary

Global Markets Direct's, 'Opsona Therapeutics Ltd. - Product Pipeline Review - 2015', provides an overview of the Opsona Therapeutics Ltd.'s pharmaceutical research and development focus.

This report provides comprehensive information on the current therapeutic developmental pipeline of Opsona Therapeutics Ltd.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects.

Global Markets Direct's report features investigational drugs from across globe covering over 20 therapy areas and nearly 3,000 indications. The report is built using data and information sourced from Global Markets Direct's proprietary databases, Company/University websites, SEC filings, investor presentations and featured press releases from company/university sites and industry-specific third party sources, put together by Global Markets Direct's team. Drug profiles/records featured in the report undergoes periodic updation following a stringent set of processes that ensures that all the profiles are updated with the latest set of information. Additionally, processes including live news & deals tracking, browser based alert-box and clinical trials registries tracking ensure that the most recent developments are captured on a real time basis.

The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Note*: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides brief overview of Opsona Therapeutics Ltd. including business description, key information and facts, and its locations and subsidiaries
  • The report reviews current pipeline of Opsona Therapeutics Ltd.'s human therapeutic division and enlists all their major and minor projects
  • The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones
  • Special feature on out-licensed and partnered product portfolio
  • The report summarizes all the dormant and discontinued pipeline projects
  • Latest company statement
  • Latest news and deals relating to the Opsona Therapeutics Ltd.'s pipeline products

Reasons to buy

  • Evaluate Opsona Therapeutics Ltd.'s strategic position with total access to detailed information on its product pipeline
  • Assess the growth potential of Opsona Therapeutics Ltd. in its therapy areas of focus
  • Identify new drug targets and therapeutic classes in the Opsona Therapeutics Ltd.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas
  • Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps
  • Develop strategic initiatives by understanding the focus areas of Opsona Therapeutics Ltd. and exploit collaboration and partnership opportunities
  • Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage
  • Plan mergers and acquisitions effectively by identifying the most promising pipeline of Opsona Therapeutics Ltd.
  • Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope
  • Explore the dormant and discontinued projects of Opsona Therapeutics Ltd. and identify potential opportunities in those areas
  • Avoid Intellectual Property Rights related issues

Table of Contents

  • Table of Contents
    • List of Tables
    • List of Figures
  • Opsona Therapeutics Ltd. Snapshot
    • Opsona Therapeutics Ltd. Overview
    • Key Information
    • Key Facts
  • Opsona Therapeutics Ltd. - Research and Development Overview
    • Key Therapeutic Areas
  • Opsona Therapeutics Ltd. - Pipeline Review
    • Pipeline Products by Stage of Development
    • Pipeline Products - Monotherapy
  • Opsona Therapeutics Ltd. - Pipeline Products Glance
    • Opsona Therapeutics Ltd. - Clinical Stage Pipeline Products
      • Phase II Products/Combination Treatment Modalities
      • Phase I Products/Combination Treatment Modalities
    • Opsona Therapeutics Ltd. - Early Stage Pipeline Products
      • Preclinical Products/Combination Treatment Modalities
      • Discovery Products/Combination Treatment Modalities
  • Opsona Therapeutics Ltd. - Drug Profiles
    • OPN-305
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • OPN-401
      • Product Description
      • Mechanism of Action
      • R&D Progress
    • Small Molecule Inflammasome Modulator Programme
      • Product Description
      • Mechanism of Action
      • R&D Progress
  • Opsona Therapeutics Ltd. - Pipeline Analysis
    • Opsona Therapeutics Ltd. - Pipeline Products by Target
    • Opsona Therapeutics Ltd. - Pipeline Products by Route of Administration
    • Opsona Therapeutics Ltd. - Pipeline Products by Molecule Type
    • Opsona Therapeutics Ltd. - Pipeline Products by Mechanism of Action
  • Opsona Therapeutics Ltd. - Recent Pipeline Updates
  • Opsona Therapeutics Ltd. - Dormant Projects
  • Opsona Therapeutics Ltd. - Locations And Subsidiaries
    • Head Office
  • Appendix
    • Methodology
    • Coverage
    • Secondary Research
    • Primary Research
    • Expert Panel Validation
    • Contact Us
    • Disclaimer

List of Tables

  • Opsona Therapeutics Ltd., Key Information
  • Opsona Therapeutics Ltd., Key Facts
  • Opsona Therapeutics Ltd. - Pipeline by Indication, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Stage of Development, 2015
  • Opsona Therapeutics Ltd. - Monotherapy Products in Pipeline, 2015
  • Opsona Therapeutics Ltd. - Phase II, 2015
  • Opsona Therapeutics Ltd. - Phase I, 2015
  • Opsona Therapeutics Ltd. - Preclinical, 2015
  • Opsona Therapeutics Ltd. - Discovery, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Target, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Route of Administration, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Molecule Type, 2015
  • Opsona Therapeutics Ltd. - Pipeline Products by Mechanism of Action, 2015
  • Opsona Therapeutics Ltd. - Recent Pipeline Updates, 2015
  • Opsona Therapeutics Ltd. - Dormant Developmental Projects,2015

List of Figures

  • Opsona Therapeutics Ltd. - Pipeline by Top 10 Indication, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Stage of Development, 2015
  • Opsona Therapeutics Ltd. - Monotherapy Products in Pipeline, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Top 10 Target, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Top 10 Route of Administration, 2015
  • Opsona Therapeutics Ltd. - Pipeline by Top 10 Molecule Type, 2015
  • Opsona Therapeutics Ltd. - Pipeline Products by Top 10 Mechanism of Action, 2015
Back to Top